Revivals Sample Clauses

Revivals. 1. In the event of a revival of the same physical production at the same Theatre in the same season, the original Director and/or Choreographer shall be afforded, in writing, the first option to conduct rehearsals for such revival. The Director and/or Choreographer shall receive as compensation no less than the original contractual fee prorated or the current minimum fee prorated, whichever is greater, for the length of time worked, provided, however, that the Theatre shall guarantee at least one (1) week’s work. 2. In the event of a revival of the same physical production at the same Theatre in a season subsequent to the season in which the play was originally produced, the original Director and/or Choreographer shall receive the benefits provided with respect to a revival in the same season, except that in addition thereto, the Director and/or Choreographer shall receive a recognition payment, beginning with the first performance of the revival, of no less than one-eighth (1/8) of twenty-five (25%) percent of either the original prorated contractual weekly fee or the stage’s prorated category minimum weekly fee, whichever is greater, for each performance. The “original prorated contractual weekly fee” is calculated by dividing the actual fee by the actual number of weeks of rehearsal. The “stage’s prorated category minimum weekly fee” is calculated by dividing the minimum fee by the minimum number of weeks of rehearsal. (See the annexed “Schedule B” for example calculations of “recognition payment,” “original prorated contractual weekly fee,” and “stage’s prorated category minimum weekly fee.”) In the event that the revival’s rehearsal period is equal to the production’s original rehearsal period, the Director and/or Choreographer shall not receive any recognition payment. 3. Where the original Director and/or Choreographer declines to conduct rehearsals for the revival, the replacement Director and/or Choreographer, if one is necessary, shall receive as compensation no less than the stage’s minimum fee, as specified in the annexed “Schedule A,” prorated for the length of time worked. (See the annexed “Schedule B” for example calculation of the “prorated category minimum weekly fee.”) 4. Where the original Director and/or Choreographer declines to conduct rehearsals for the revival, and the rehearsal period of the revival is equal to the minimum number of weeks of employment for the stage’s category, as specified in the annexed “Schedule A,” the original...
AutoNDA by SimpleDocs
Revivals. In the event of a revival of the choreography following a gap of at least 20 weeks a third of the initial fee will be paid, together with the weekly royalty for each week in which the choreography is performed. In the event that any further work is required of the Choreographer this will be paid for at the daily or weekly rate as appropriate.
Revivals. Upon the revival by Employer of any production using the same fight choreography, the Fight Director will be offered re-engagement as the Fight Director if the fight choreography is extended or complex, provided, however, that the Fight Director’s domicile is the City of Origination at the time of such revival. No later than the opening night of the final production of each season, Employer will inform AGMA and the Fight Director(s) in writing if the fight choreography for each production meets the standard for re-engagement.
Revivals. For each revival of a production by Company, the Stage Director and/or Choreographer, if not engaged to direct or choreograph the revival production, shall receive a royalty of not less than 5% of their contractual fee for the original production, provided that the Director’s original staging or the Choreographer’s original choreography is used in the revival.

Related to Revivals

  • Reinstatements If a policy reinsured on an automatic basis is reinstated in accordance with its terms or the rules of the Company, as provided to the Reinsurer, the Reinsured Policy will be reinstated automatically by the Reinsurer. The Reinsurer's approval is required only for the reinstatement of a facultative policy when the Company's regular reinstatement rules indicate that more evidence than a Statement of Good Health is required. The Company's liability with respect to the premiums in arrears is set out in Exhibit F.

  • Applications To the extent that any provision of any Application related to any Letter of Credit is inconsistent with the provisions of this Section 3, the provisions of this Section 3 shall apply.

  • Renewals In the case of the renewal of a Euro-Rate Option at the end of an Interest Period, the first day of the new Interest Period shall be the last day of the preceding Interest Period, without duplication in payment of interest for such day.

  • Maintenance of Licenses The Owner Trustee will obtain and maintain any licenses that the Administrator informs the Owner Trustee are required to be obtained or maintained by the Owner Trustee under the laws of any State in connection with the Owner Trustee’s duties and obligations under the Transaction Documents.

  • Patents As to any patentable subject matter contained in the deliverables, the Contractor agrees to disclose such patentable subject matter to the City. Further, if requested by the City, the Contractor agrees to assign and, if necessary, cause each of its employees to assign the entire right, title, and interest to specific inventions under such patentable subject matter to the City and to execute, acknowledge, and deliver and, if necessary, cause each of its employees to execute, acknowledge, and deliver an assignment of letters patent, in a form to be reasonably approved by the City, to the City upon request by the City.

  • Maintenance of Patents 11 5.5. Prosecution of Patent Application................................. 11 5.6.

  • Prosecution and Maintenance of Patents (a) Subject to any Adolor third party agreements, Adolor shall prepare, file prosecute and maintain in the Territory and at its own costs, upon consultation with Santen, the Adolor Patents and any jointly owned patents. Adolor shall notify Santen of the status of all patent filings (including, without limitation, the grant of any Adolor Patents) and, upon the request of Santen, shall provide advance copies of any papers relating to the filing, prosecution, or maintenance of such Adolor Patents. For Adolor Patents and patent applications, and for jointly owned patents and patent applications, Santen shall reimburse Adolor for one-half of any and all costs for the filing, prosecution, or maintenance of such patents and patent applications incurred by Adolor. Adolor shall submit an invoice for reimbursement of such patent costs to Santen and Santen shall pay such invoice within thirty (30) days of submission by Adolor. Santen shall have the right to audit the patent costs subject to reimbursement once per year. Such audit rights shall expire twenty- four (24) months after an invoice is submitted by Adolor for payment. (b) Subject to Section 8.04 (b), all amounts for patent applications paid by Santen under Section 8.02 (a) for each country of the Territory shall be creditable on a country-by-country basis against future Royalties payable to Adolor by Santen for each such country; provided, however, that no more than **% of the Royalties payable for any period in such country shall be paid by crediting amounts paid by Santen under Section 8.02(a), and further **=Certain information on this page has been omitted and filed separately with the Commission. Confidential treatment has been requested with respect to the omitted portions. provided that Santen may carry forward all amounts paid under Section 8.02(a) for crediting against future Royalties in such country under this Section 8.02(b) until such amounts are exhausted.

  • Registrations Except pursuant to licenses and other user agreements entered into by each Loan Party in the ordinary course of business that are listed in Schedule 12(a) or 12(b) to the Perfection Certificate, on and as of the date hereof (i) each Loan Party owns and possesses the right to use, and has done nothing to authorize or enable any other person to use, any copyright, patent or trademark (as such terms are defined in the Security Agreement) listed in Schedule 12(a) or 12(b) to the Perfection Certificate and (ii) all registrations listed in Schedule 12(a) or 12(b) to the Perfection Certificate are valid and in full force and effect.

  • Prosecution and Maintenance of Patent Rights (a) At the initiative of ProPhase or Licensor, the Parties shall consult in good faith with each other regarding the filing, prosecution, and maintenance of all Licensed Patents. The Licensed Patents shall be diligently filed, prosecuted and maintained by Licensor using reputable counsel. Licensor shall keep ProPhase reasonably informed with regard to the preparation, filing, prosecution, and maintenance of the Licensed Patents, including by providing ProPhase (or its designee) copies of office actions issued from patent offices, proposed responses to such office actions, and any other patent related filings, to be made to such patent authority in the Territory sufficiently in advance of submitting such filings or responses so as to allow for a reasonable opportunity for ProPhase to review and comment thereon. Licensor shall consider in good faith any such comments for incorporation into such draft. Licensor represents that during the Term that (a) all Licensed Patents will be diligently prosecuted in the respective patent offices in the Territory in accordance with applicable laws, rules and regulations, (b) all Licensed Patents will be filed and maintained properly and correctly, (c) Licensor will pay all applicable fees on or before the due date for payment, and (d) all Licensed Patents will identify each and every inventor of the claims thereof as determined in accordance with the laws of the jurisdiction in which such Patent is filed. Prophase shall reimburse Global BioLife for reasonable attorney fees and patent office costs associated with the prosecution and maintenance of the Licensed Patents on a quarterly basis commencing on September 30, 2022. (b) If, at any time during the Term, the Parties may mutually agree that it is undesirable, as to one or more countries, to file, prosecute or maintain any Licensed Patent, then Global BioLife shall have discretion to refrain from filing, prosecuting and/or maintaining any Licensed Patent or permitting the Licensed Patent to lapse. (c) The Parties shall cooperate with each other and discuss, in good faith, the Patent Rights within the Licensed Patents Covering the Licensed Compound and Licensed Products to enable Prophase to make filings with Regulatory Authorities, as required or allowed in connection with (A) in the United States, the FDA’s Orange Book and (B) outside the United States, under the national implementations of Article 10.l(a)(iii) of Directive 2001/EC/83 or other international equivalents thereof. Global BioLife shall cooperate with Prophase’s reasonable requests in connection therewith, including meeting any submission deadlines, in each case, to the extent required or permitted by applicable law. (d) The Parties shall cooperate in obtaining Patent Term Extensions pursuant to 35 U.S.C. § 156 and foreign counterparts and equivalents thereof, including supplementary protection certificates, to the extent such extensions are available with respect to the applicable Patent Rights (“Extension Activities”).

  • Extensions If a Registry Operator offers additional Registry Services that require submission of additional data, not included above, additional “extension schemas” shall be defined in a case by case basis to represent that data. These “extension schemas” will be specified as described in Part A, Section 9, reference 2 of this Specification. Data related to the “extensions schemas” will be included in the deposit file described in Part A, Section 3.1 of this Specification. ICANN and the respective Registry Operator shall work together to agree on such new objects’ data escrow specifications.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!